What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q2 2017?

11 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock
Shares outstanding: 115,694,154
Total 13F shares: 1,568,425
Share change: +798,824
Total reported value: $1,692,000
Price per share: $1.08
Number of holders: 11
Value change: +$856,257
Number of buys: 5
Number of sells: 3

Security key

92686J106

Report period

Q2 2017

Institutions

Top holders

VKTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2017 Previous quarter: Q1 2017 Viking Therapeutics, Inc. SEC filings Viking Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92686J106

Newer quarter: Q3 2017 Previous quarter: Q1 2017

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

VANGUARD GROUP INC

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2017

13F Lead comparable stake: 0.29% Showing first 8 of 12 holder rows. Open remaining rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	0.29%	$483,000 330,689 shares	—	31 Mar 2017
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.23%	$388,000 265,800 shares	—	31 Mar 2017
SHEPHERD KAPLAN KROCHUK, LLC	13F Company 13F	0.09%	$152,000 103,978 shares	—	31 Mar 2017
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.03%	$45,000 31,264 shares	—	31 Mar 2017
NORTHERN TRUST CORP	13F Company 13F	0.01%	$25,000 16,962 shares	—	31 Mar 2017
Acrospire Investment Management LLC	13F Company 13F	0.01%	$18,000 12,642 shares	—	31 Mar 2017
UBS Group AG	13F Company 13F	0%	$7,000 4,506 shares	—	31 Mar 2017
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F Company 13F	0%	$3,000 1,807 shares	—	31 Mar 2017

Show 4 additional holder rows in the full holder list

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
REILLY FINANCIAL ADVISORS, LLC	13F Company 13F	0%	$2,000 1,250 shares	—	31 Mar 2017
BlackRock Finance, Inc.	13F Company 13F	0%	$1,000 703 shares	—	31 Mar 2017
Advisor Group, Inc.	13F Company 13F	0%	$1,000 500 shares	—	31 Mar 2017
MORGAN STANLEY	13F Company 13F	0%	$1,000 398 shares	—	31 Mar 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,568,425

Rows loaded

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 value	Q2 2017 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend